Related references
Note: Only part of the references are listed.Alkaline Phosphatase in Women with Osteoporosis
A. G. Hulth et al.
ACTA MEDICA SCANDINAVICA (2010)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
SERMs in the prevention and treatment of postmenopausal osteoporosis: an update
Jaime Kulak Junior et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2010)
The association between serum thyrotropin (TSH) levels and bone mineral density in healthy euthyroid men
Beom-Jun Kim et al.
CLINICAL ENDOCRINOLOGY (2010)
Prevalence and Predictors of Osteoporosis Risk in Orthopaedic Patients
Tamara D. Rozental et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2010)
Axial and appendicular bone density predict fractures in older women
Dennis M. Black et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Thyroid Function within the Upper Normal Range Is Associated with Reduced Bone Mineral Density and an Increased Risk of Nonvertebral Fractures in Healthy Euthyroid Postmenopausal Women
Elaine Murphy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A survey of bone mineral density of healthy Han adults in China
H. Zhu et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
Jun Jun Iwamoto
Therapeutics and Clinical Risk Management (2010)
Low Bone Mineral Density and Impaired Bone Metabolism in Young Alcoholic Patients Without Liver Cirrhosis: A Cross-Sectional Study
Peter Malik et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Bone mass in schizophrenia and normal populations across different decades of life
Jenn-Huei Renn et al.
BMC MUSCULOSKELETAL DISORDERS (2009)
Lithium's effect on bone mineral density
Ali Zamani et al.
BONE (2009)
Osteoporosis: An Age-Related and Gender-Specific Disease - A Mini-Review
Peter Pietschmann et al.
GERONTOLOGY (2009)
Risk factors for postmenopausal osteoporosis: anthropometric measurements, age, age at menopause and the time elapsed after menopause onset
Nurten Akdeniz et al.
GYNECOLOGICAL ENDOCRINOLOGY (2009)
Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation
Laura Gray et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
Jari Tiihonen et al.
LANCET (2009)
Search for secondary osteoporosis: are Z scores useful predictors?
K. Swaminathan et al.
POSTGRADUATE MEDICAL JOURNAL (2009)
Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials
Christoph U. Correll et al.
SCHIZOPHRENIA BULLETIN (2009)
Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor κB ligand/osteoprotegerin ratio
Dutmanee Seriwatanachai et al.
BONE (2008)
Assessment of Clinical Risk Factors to Validate the Probability of Osteoporosis and Subsequent Fractures in Korean Women
Yoo Mee Kim et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Male osteoporosis: new insights in an understudied disease
Elizabeth M. Haney et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia
Taishiro Kishimoto et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Clozapine interacts with the glycine site of the NMDA receptor: Electrophysiological studies of dopamine neurons in the rat ventral tegmental area
Lilly Schwieler et al.
LIFE SCIENCES (2008)
Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole
Mong-Liang Lu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Equivalent switching dose from oral risperidone to risperidone long-acting injection: A 48-week randomized, prospective, single-blind pharmacokinetic study
Ya Mei Bai et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Bone mineral density changes over a year in young females with schizophrenia: Relationship to medication and endocrine variables
A. M. Meaney et al.
SCHIZOPHRENIA RESEARCH (2007)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to clozapine for the treatment of schizophrenia
Hsien-Yuan Lane et al.
BIOLOGICAL PSYCHIATRY (2006)
Comparison and problems of measured values of LH, FSH, and PRL among measurement systems
T Iwasa et al.
ENDOCRINE JOURNAL (2006)
Down-regulation of N-methyl D-aspartate receptor in rat-modeled disuse osteopenia
ML Ho et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatment
OD Howes et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Antipsychotic drugs - A new risk factor for osteoporosis in young women with schizophrenia?
V O'Keane et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
The role of parathyroid hormone in the management of osteoporosis
CJ Rosen
HORMONE RESEARCH (2005)
Osteoporosis in patients with schizophrenia
M Hummer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
A summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia.
RW Buchanan et al.
SCHIZOPHRENIA BULLETIN (2005)
Secondary osteoporosis: Underlying disease and the risk for glucocorticoid-induced osteoporosis
EP Boling
CLINICAL THERAPEUTICS (2004)
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia
AM Meaney et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Schizophrenia and osteoporosis
M Lean et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2004)
Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: A prospective study
G Abraham et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Risperidone, but not olanzapine, decreases bone mineral densitv in female premenopausal schizophrenia patients
D Becker et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism
L Wawrzynska et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Clozapine treatment for suicidality in schizophrenia - International Suicide Prevention Trial (InterSePT)
HY Meltzer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
JM Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Diagnosis of osteoporosis and assessment of fracture risk
JA Kanis
LANCET (2002)
Substance misuse in patients with schizophrenia - Epidemiology and management
DJ Kavanagh et al.
DRUGS (2002)
Substance abuse in schizophrenia:: a review of the literature and a study of correlates in Sweden
E Cantor-Graae et al.
SCHIZOPHRENIA RESEARCH (2001)
Share Paper
